{"id":40116,"date":"2022-03-09T05:07:32","date_gmt":"2022-03-09T05:07:32","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=88081"},"modified":"2022-03-09T05:07:32","modified_gmt":"2022-03-09T05:07:32","slug":"from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd","status":"publish","type":"post","link":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/","title":{"rendered":"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD"},"content":{"rendered":"

Chip Wilson suffers from a rare form of muscular dystrophy and seeks scientific innovators to find a cure to help him and others<\/h3>\n

VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) — The world\u2019s most successful entrepreneurs are often willing to share how lessons learned and resilience have shaped their business sense, but few transcend their successes to optimistically forge a path to overcome one\u2019s biggest challenge \u2013 their health.<\/p>\n

Going public with his own story, Wilson, who was diagnosed with Facioscapulohumeral muscular dystrophy type 2 (FSHD2) at age 32, announced he has\u00a0committed $100 million and created a new venture<\/strong>,<\/strong>\u00a0Solve FSHD<\/strong><\/a>,<\/strong>\u00a0with the objective of finding a cure for FSHD by 2027, targeting the underlying genetic cause or improving muscle function and growth.<\/p>\n

\u201cSolve FSHD will accelerate the underfunded development of drugs and therapies to stop muscle degeneration, increase muscle strength and improve the quality of life for those living with this,\u201d said Wilson, who stopped playing squash 10 years ago because he could no longer lift a racquet over his head.<\/p>\n

At 67, the serial entrepreneur and father of five boys says his upper body is \u201cvery wasted.\u201d His legs have lost significant muscle tissue and Wilson can see a time in the not-so-distant future when he will need the assistance of a wheelchair.<\/p>\n

\u201cI can still walk, but I must be very intentional and present, or I will trip and fall. I do see a day when I will be unable to walk on my own,\u201d said the Canadian entrepreneur and venture philanthropist. Currently, there is no cure for FSHD, a genetic disorder that has varying symptoms, severity, and progression. According to the Mayo Clinic, muscle weakness usually starts in the face, hip and shoulders. Onset usually occurs in the teenage years but can begin in childhood.<\/p>\n

\u201cIt\u2019s one of the most prevalent adult muscular dystrophies. The investments of Solve FSHD now to help validate biomarkers and develop new therapies will pay dividends later for any company or researcher pursuing better therapies for FSHD.\u00a0These investments form the foundation to support future clinical trials and serve as a seed for further funding and investment,\u201d adds Dr. Jeffrey Statland, Assistant Professor of Neurology at the University of Kansas Medical Center. Dr. Statland has conducted clinical and research training in neuromuscular diseases, with a primary interest in FSHD.<\/p>\n

\u201cSolve FSHD will support projects that normally wouldn\u2019t receive funding, including bottlenecks in the pipeline and thereby accelerating the development of clinical trials and novel therapies. We can move quickly and pursue multiple projects simultaneously,\u201d Wilson said.<\/p>\n

Scientists, biotech and biopharma companies, muscular degeneration specialists and other researchers working in similar muscular dystrophy fields are all encouraged to contact Solve FSHD. Solve FSHD is seeking to fund or invest in potential research partners, companies, and clinicians interested in advancing related research and clinical trials.<\/p>\n

Solve FSHD also wants to hear from those with FSHD or who suspect they may have it, who can help by volunteering to join a contact registry for clinical trials.<\/p>\n

\u201cFSHD is life-altering and I know my future will be challenging,\u201d said Wilson. \u201cI prefer not to sit in the stands but go out on the courts with my time and money to help this important cause so very close to my heart. In this way, there is something to smile about for those touched by FSHD.\u201d<\/p>\n

About Solve FSHD<\/strong>
\nSolve FSHD is funding innovative biotech and biopharma research and development activities that accelerate novel treatments of Facioscapulohumeral muscular dystrophy (FSHD) treatment. It is fully funded and created by Canadian entrepreneur and philanthropist Chip Wilson. The founder of yoga-inspired athletic apparel company Lululemon Athletica inc. has been living with FSHD for the last three decades of his life. He has committed $100 million of his own money to create Solve FSHD and kick-start funding into projects that fit the organization\u2019s mission: accelerate research into new therapies and find a cure for the disorder by 2027.<\/p>\n

Future announcements for grant funding will be issued on Solve FSHD\u2019s website –\u00a0https:\/\/solvefshd.com\/<\/a><\/p>\n

For early-stage companies, contact Solve FSHD at\u00a0info@solvefshd.com<\/a>.<\/p>\n

If you have FSHD and want to find out about clinical trials or be included in the FSHD registry, please see Solve FSHD\u2019s website –\u00a0https:\/\/solvefshd.com\/<\/a><\/p>\n

For media inquiries or to request a media interview, please contact:<\/strong>
\nKamran Shaikh, Account Director
\nPR Associates
\nkshaikh@prassociates.com<\/a>
\n778-846-5406<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Chip Wilson suffers from a rare form of muscular dystrophy and seeks scientific innovators to find a cure to help him and others VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) \u2014 The world\u2019s most successful entrepreneurs are often willing to share how lessons learned and resilience have shaped their business sense, but few transcend [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[10,12],"yoast_head":"\nFrom apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD - Times South Africa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD - Times South Africa\" \/>\n<meta property=\"og:description\" content=\"Chip Wilson suffers from a rare form of muscular dystrophy and seeks scientific innovators to find a cure to help him and others VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) \u2014 The world\u2019s most successful entrepreneurs are often willing to share how lessons learned and resilience have shaped their business sense, but few transcend [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/\" \/>\n<meta property=\"og:site_name\" content=\"Times South Africa\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-09T05:07:32+00:00\" \/>\n<meta name=\"author\" content=\"TSA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"TSA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/\"},\"author\":{\"name\":\"TSA\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1\"},\"headline\":\"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD\",\"datePublished\":\"2022-03-09T05:07:32+00:00\",\"dateModified\":\"2022-03-09T05:07:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/\"},\"wordCount\":743,\"publisher\":{\"@id\":\"https:\/\/timessouthafrica.com\/#organization\"},\"keywords\":[\"Africa\",\"South Africa\"],\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/\",\"url\":\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/\",\"name\":\"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD - Times South Africa\",\"isPartOf\":{\"@id\":\"https:\/\/timessouthafrica.com\/#website\"},\"datePublished\":\"2022-03-09T05:07:32+00:00\",\"dateModified\":\"2022-03-09T05:07:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/timessouthafrica.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/timessouthafrica.com\/#website\",\"url\":\"https:\/\/timessouthafrica.com\/\",\"name\":\"Times South Africa\",\"description\":\"Where Africa Comes First\",\"publisher\":{\"@id\":\"https:\/\/timessouthafrica.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/timessouthafrica.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/timessouthafrica.com\/#organization\",\"name\":\"Times South Africa\",\"url\":\"https:\/\/timessouthafrica.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png\",\"contentUrl\":\"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png\",\"width\":200,\"height\":57,\"caption\":\"Times South Africa\"},\"image\":{\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1\",\"name\":\"TSA\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/timessouthafrica.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"TSA\"},\"url\":\"https:\/\/timessouthafrica.com\/author\/tsa\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD - Times South Africa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/","og_locale":"en_US","og_type":"article","og_title":"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD - Times South Africa","og_description":"Chip Wilson suffers from a rare form of muscular dystrophy and seeks scientific innovators to find a cure to help him and others VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) \u2014 The world\u2019s most successful entrepreneurs are often willing to share how lessons learned and resilience have shaped their business sense, but few transcend [\u2026]","og_url":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/","og_site_name":"Times South Africa","article_published_time":"2022-03-09T05:07:32+00:00","author":"TSA","twitter_card":"summary_large_image","twitter_misc":{"Written by":"TSA","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/#article","isPartOf":{"@id":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/"},"author":{"name":"TSA","@id":"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1"},"headline":"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD","datePublished":"2022-03-09T05:07:32+00:00","dateModified":"2022-03-09T05:07:32+00:00","mainEntityOfPage":{"@id":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/"},"wordCount":743,"publisher":{"@id":"https:\/\/timessouthafrica.com\/#organization"},"keywords":["Africa","South Africa"],"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/","url":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/","name":"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD - Times South Africa","isPartOf":{"@id":"https:\/\/timessouthafrica.com\/#website"},"datePublished":"2022-03-09T05:07:32+00:00","dateModified":"2022-03-09T05:07:32+00:00","breadcrumb":{"@id":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/timessouthafrica.com\/from-apparel-to-clinical-trials-lululemon-founder-commits-100-million-to-find-cure-for-fshd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/timessouthafrica.com\/"},{"@type":"ListItem","position":2,"name":"From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD"}]},{"@type":"WebSite","@id":"https:\/\/timessouthafrica.com\/#website","url":"https:\/\/timessouthafrica.com\/","name":"Times South Africa","description":"Where Africa Comes First","publisher":{"@id":"https:\/\/timessouthafrica.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/timessouthafrica.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/timessouthafrica.com\/#organization","name":"Times South Africa","url":"https:\/\/timessouthafrica.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/","url":"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png","contentUrl":"https:\/\/timessouthafrica.com\/wp-content\/uploads\/2023\/09\/22.png","width":200,"height":57,"caption":"Times South Africa"},"image":{"@id":"https:\/\/timessouthafrica.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/timessouthafrica.com\/#\/schema\/person\/3b17cd6e128204bbcfbfa7ed541048b1","name":"TSA","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/timessouthafrica.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"TSA"},"url":"https:\/\/timessouthafrica.com\/author\/tsa\/"}]}},"_links":{"self":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/posts\/40116"}],"collection":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/comments?post=40116"}],"version-history":[{"count":0,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/posts\/40116\/revisions"}],"wp:attachment":[{"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/media?parent=40116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/categories?post=40116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/timessouthafrica.com\/wp-json\/wp\/v2\/tags?post=40116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}